Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Ticker ANGI · Nasdaq · DE
Angi Inc. is a U.S. business entity operating within the Mailing, Reproduction & Stenographic sector (SIC 7310). Publicly traded on the Nasdaq under the ticker symbol ANGI, the company is incorporated in Delaware. Based on SEC EDGAR filings, ANGI reported fiscal year 2025 revenue of $1.03B, reflecting a year-over-year decline of 13.0%. Our proprietary Semantic Risk Score of 14 indicates high transparency and low reporting risk, derived from the frequency and consistency of 10-K, 10-Q, and 8-K filing patterns. As part of the SIC 7310 classification, Angi Inc. serves as a key benchmark for investors and analysts monitoring Delaware corporate performance.
Comparison based on Standard Industrial Classification (SIC) mapping from SEC EDGAR filings.
Filing data sourced from SEC EDGAR signals. 10-K = annual report · 10-Q = quarterly · 8-K = material event.
Angi Inc. (ANGI) — Key efficiency & solvency metrics · FY2025
Operating Margin
Sector avg: -69.33%
Net Margin
Sector avg: -72.66%
Current Ratio
Sector avg: 1.81
| Key Metric | Company | Industry Avg | Status |
|---|---|---|---|
| Total RevenueYoY: -13% | $1.03B | $257.7M | ▲ Outperform |
| Operating MarginOperating income as % of revenue | 6.3% | -69.33% | ▲ Outperform |
| Net MarginNet income as % of revenue | 0% | -72.66% | ▲ Outperform |
| Current RatioCurrent assets / current liabilities. Above 1.0 = solvent. | 1.65 | 1.81 | ▼ Lagging |
Source: SEC EDGAR XBRL filings (10-K annual reports). Industry benchmarks derived from 17 companies in SIC 7310.
Disclaimer: All financial data is sourced from raw SEC EDGAR filings. Sprytne.com provides automated data visualization and algorithmic analysis for informational purposes only. This is NOT financial advice, a recommendation to buy/sell, or a guarantee of accuracy. Always verify data via official SEC sources before making investment decisions.
Federal Contracts
CSICS, AAR APPROVED, EXCEL TECHNOLOGIES V8, POP 2/1/2019-2/28/2023, AQM SUZAN STAGE, COR ANGIE MITCHELL, PM KAREN MOON
CSAOS, AAR APPROVED, MBL TECHNOLOGIES, POP 2/1/2019-1/31/2020, CO SUZAN STAGE, COR ANGIE MITCHELL, PM KAREN MOON
RFQ 2032H5-18-Q-00005 BUYER: LUIS PENA (703)336-4069 TECHNICAL EXPERT: ANGIE SENSEL (304)264-7286 THE OBJECTIVE OF THIS REQUIREMENT IS TO PURCHASE RENEWAL PALO ALTO FIREWALL MAINTENANCE, FOR THE IRS TELECOMMUNICATIONS INFRASTRUCTURE AND IT IS TO BE PERFORMED IN ACCORDANCE WITH THE ATTACHED SOW, VENDOR'S RESPONSE DATED 11/20/2017, AND THE TERMS AND CONDITIONS OF THE AWARD.
THE ANGIO CT SUITE UPGRADE AT THE RALPH H. JOHNSON CHARLESTON VA MEDICAL CENTER IS A SITE PREPARATION PROJECT THAT RENOVATES A PORTION OF THE IMAGING SUITE TO INSTALL NEW IR, CT, AND IR/CT EQUIPMENT.
RADIOLOGY REGISTERED NURSE, MRI TECHNOLOGIST, COMPUTED TOMOGRAPHY TECHNOLOGIST, ANGIOGRAPHY TECHNOLOGIST, ULTRASOUND TECHNOLOGIST, MAMMOGRAPHY TECHNOLOGIST, NUCLEAR MEDICINE TECHNOLOGIST, RADIOLOGY TECHNOLOGIST, MEDICAL DOSIMETRIST, RADIATION THERAPIST, AND CHIEF RADIATION THERAPIST SERVICES
TOSHIBA XR CATH LAB INFNIX I 40 ANGIO AUILION ONE
8509979444!RAD-FLUORO ANGIO SYS
528A7-08-702, RENOVATE IMAGING FOR ANGIO & CT 528A7-08-709, RENOVATE 5 SOUTH FOR OUTPATIENT PT 528A7-08-704, RENOVATE FOR LOW VISION 528A7-08-705, REPLACE ICU LAV/TOILET UNITS 528A7-08-708, REMODEL CANTEEN DINING ROOM 528A7-07-703, RENOVATE HISTOLOGY C368 528A7-08-710, RENOVATE SPEECH PATHOLOGY 528A7-08-711, RENOVATE IMAGING READING 528A7-08-733, RENOVATE X-RAY A328
4505803231!ANGIO
8510684897!FLUOROSCOPIC ANGIOGRAPHY SYST
Source: USAspending.gov (Official Federal Award Data). Reflects prime contracts only. Last sync: 2026-03-30.
Compared to 25 peers in Mailing, Reproduction & Stenographic (SIC 7310)
Revenue
SEC EDGAR XBRL filings by fiscal year
Side-by-side financial showdown — revenue, margins, and growth.
Methodology & compliance note
Data is aggregated from SEC EDGAR and Secretary of State public records. Any analytics such as "market share" are statistical estimates (proxy models) and are not official audits, valuations, or investment advice. Sprytne.com is an independent data aggregator and is not affiliated with any government agency.Learn more →